Retina

Surgeon offers some cautionary tales about unfortunate cases he has encountered

Study: AI can detect swelling, severity of that swelling in macula of patients with diabetes

Ongoing study aims to clarify patient selection for endpoint management

Check out the latest from the Medical News Minute

Letters to the Editor may be submitted to [email protected]. Letters may be edited for clarity and length.

Ophthalmology benefiting from active programs for innovative product development in 2018 and onward

Novel transparent, head-wearable camera display aims to make ophthalmic surgery more precise

Combination therapy benefits from laser in the mix for DME, other conditions

Increasingly, UWF imaging is becoming standard practice in diabetic retinopathy and retinal vein occlusion, as well as providing important insights into the management of retinopathy of prematurity and rare hereditary retinal vascular conditions.

Ragui Sedeek, MD, shares four pearls on how you can discuss diabetic treatments with your patients.

Diabetic eye disease is occurring in younger populations, which means it's time to rethink anti-VEGF standards.

In the first part of his Clinical Innovation series, Josh Mali, MD, shares how this novel home-use device is the new standard of care for AMD monitoring. Future blogs in the series will discuss the increased efficacy of patient monitoring and present case examples.

Most commercially available OCT and OCTA devices can provide widefield OCTA through a combination of faster speeds, tracking, and the ability to montage images. This may revolutionize clinicians’ ability to assess and quantify retinal vascular disease.

Lamellar holes usually don’t require treatment, but it is important to recognize the eyes that may benefit from vitrectomy.

Using ultrasonic power to actuate a vitrectomy probe (hypersonic vitrectomy) allows for a “smooth steady flow of vitreous into a port that is oscillating at 1.7 million cycles per minute,” according to Carl C. Awh, MD.

A retinectomy performed under air using a sequenced approach can improve outcomes.

As another year comes to an end, five members of Ophthalmology Times Europe’s Editorial Advisory Board reflect and share their perspectives on the exciting opportunities that lie ahead for ophthalmologists in 2018, whilst also considering the potential challenges.

The metastatic prognosis does not increase when vitrectomy is performed at the time of brachytherapy.